For Amarin to immediately pursue an Authorized Generic version of Vascepa
22 Comments
S
Stock Holder
5 years ago
please consider something to make this right.
S
Surjyendu Dhal
5 years ago
Ag
S
Sree
5 years ago
Featured
Negotiate with generics for win/win strategy for market maturation with limits to market share. Please sell the company to BP for AG strategy. BP would have the resources to maximize sales and profits in this approach.
M
Mark Sorenson
5 years ago
I really want you to sell the company I have waited a long time and realize AMRN cant handle V
P
PTA
5 years ago
Featured
Secure a generic OR sell to statin BP to market a combo pack stat.
Remove the CEO immediately.
E
Eric L
· petition starter
5 years ago
This is the right move for patients and shareholders.
A
Anonymous
5 years ago
Shareholder having large stakes. Generic Vascepa please
C
Chris
5 years ago
Please do the right thing.
V
Victor Alan
5 years ago
Take over the market - only move.
M
Max NPV
5 years ago
Agreed...see my name.
A
Anonymous
5 years ago
Must act now!!!!
R
Rehan Asi
5 years ago
Launch and authorized generic now or sell the company.!
J
James Smith
5 years ago
Agree...Make Amarin a Blockbuster
S
Sitansh Patel
5 years ago
Please produce generic version of Vascepa.
W
William R
5 years ago
Featured
Dear Mr. Thero,
You need to beat generics at their own game. Make it difficult for them to enter the market and gain an edge by making a generic of Vasepa. Cc’d
M
Marcus Teo
5 years ago
Featured
Offense is indeed the best defense. Launching generics now may cut our margins in the short run but that is bound to happen when generics arrive. However, we need to eat the humble pie now in order to secure a dominant position in the long run, and fending off generic entry will allow us to retain our majority market share. We urge Amarin not to drop this ball.
K
Kevin cogan
5 years ago
Agree
C
Clayton Johnson
5 years ago
I respectfully approve this!
A
AJ Lane
5 years ago
Featured
Mr. Thero, Please do not wait for generics to launch! Contracts should already have been secured with all major pharmacies for Amarin’s VASCEPA to be THE one and only generic offered in the US. Why wait for generics to make the first move? Shut them out NOW and take back 100% of our rightful US market! Signed an extremely dissatisfied owner of 128,400 shares.
A
Anonymous
5 years ago
Featured
Both of us have been on Vascepa for 4 years and don't want to be forced to take some junk generic by ins. co.
please consider something to make this right.
Ag
Negotiate with generics for win/win strategy for market maturation with limits to market share. Please sell the company to BP for AG strategy. BP would have the resources to maximize sales and profits in this approach.
I really want you to sell the company I have waited a long time and realize AMRN cant handle V
Secure a generic OR sell to statin BP to market a combo pack stat. Remove the CEO immediately.
This is the right move for patients and shareholders.
Shareholder having large stakes. Generic Vascepa please
Please do the right thing.
Take over the market - only move.
Agreed...see my name.
Must act now!!!!
Launch and authorized generic now or sell the company.!
Agree...Make Amarin a Blockbuster
Please produce generic version of Vascepa.
Dear Mr. Thero, You need to beat generics at their own game. Make it difficult for them to enter the market and gain an edge by making a generic of Vasepa. Cc’d
Offense is indeed the best defense. Launching generics now may cut our margins in the short run but that is bound to happen when generics arrive. However, we need to eat the humble pie now in order to secure a dominant position in the long run, and fending off generic entry will allow us to retain our majority market share. We urge Amarin not to drop this ball.
Agree
I respectfully approve this!
Mr. Thero, Please do not wait for generics to launch! Contracts should already have been secured with all major pharmacies for Amarin’s VASCEPA to be THE one and only generic offered in the US. Why wait for generics to make the first move? Shut them out NOW and take back 100% of our rightful US market! Signed an extremely dissatisfied owner of 128,400 shares.
Both of us have been on Vascepa for 4 years and don't want to be forced to take some junk generic by ins. co.